Astrana Health Narrows FY2026 Sales Guidance from $3.800B-$4.100B to $3.900B-$4.000B vs $3.980B Est
Benzinga Newsdesk 1 day ago
NewsGuidance
Astrana Health (NASDAQ:ASTH) narrows FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.900 billion-$4.000 billion vs $3.980 billion estimate.
Astrana Health (NASDAQ:ASTH) narrows FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.900 billion-$4.000 billion vs $3.980 billion estimate.